An Integrin Binding-defective Mutant of Insulin-like Growth Factor-1 (R36E/R37E IGF1) Acts as a Dominant-negative Antagonist of the IGF1 Receptor (IGF1R) and Suppresses Tumorigenesis but Still Binds to IGF1R

Ítems similars

• Cross-talk between Integrin α6β4 and Insulin-like Growth Factor-1 Receptor (IGF1R) through Direct α6β4 Binding to IGF1 and Subsequent α6β4-IGF1-IGF1R Ternary Complex Formation in Anchorage-independent Conditions
  per: Fujita, Masaaki, et al.
  Publicat: (2012)
• Insulin-like Growth Factor (IGF) Signaling Requires αvβ3-IGF1-IGF Type 1 Receptor (IGF1R) Ternary Complex Formation in Anchorage Independence, and the Complex Formation Does Not Require IGF1R and Src Activation
  per: Fujita, Masaaki, et al.
  Publicat: (2013)
• The Direct Binding of Insulin-like Growth Factor-1 (IGF-1) to Integrin αvβ3 Is Involved in IGF-1 Signaling
  per: Saegusa, Jun, et al.
  Publicat: (2009)
• Direct integrin binding to insulin-like growth factor-2 through the C-domain is required for insulin-like growth factor receptor type 1 (IGF1R) signaling
  per: Cedano Prieto, Dora Maria, et al.
  Publicat: (2017)
• Crosstalk between insulin-like growth factor (IGF) receptor and integrins through direct integrin binding to IGF1
  per: Takada, Yoshikazu, et al.
  Publicat: (2017)